Silence Therapeutics said it had formed a strategic collaboration arrangement with AstraZeneca to develop therapeutics for the treatment of cardiovascular, renal, metabolic and respiratory diseases....
Ondrej Vlcek, Chief Executive Officer, exercised 1,456,280 shares in the company on the 23rd March 2020 at a price of 88.00p. The Director now holds...
Ondrej Vlcek, Chief Executive Officer, exercised 2,912,917 shares in the company on the 23rd March 2020 at a price of 136.00p. The Director now holds...